60 DEGREES PHARMACEUTICALS, INC. Quarterly Cost of Revenue in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
60 Degrees Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2022 to Q3 2024.
  • 60 Degrees Pharmaceuticals, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $112K, a 56.9% increase year-over-year.
  • 60 Degrees Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $413K.
  • 60 Degrees Pharmaceuticals, Inc. annual Cost of Revenue for 2023 was $475K, a 9.76% increase from 2022.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $413K $112K +$40.5K +56.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $372K $89.6K -$94.4K -51.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $467K $65.4K -$7.68K -10.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $475K $146K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $71.2K -$21.1K -22.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $184K +$96.9K +111% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $73.1K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $92.3K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $87.1K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.